Hematocrit above 30% in continuous ambulatory peritoneal dialysis patients treated with erythropoietin is harmful.
Junor
B J
BJ
Renal Unit, Western Infirmary, Glasgow, U.K.
D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D010531:Peritoneal Dialysis, Continuous Ambulatory
D004921:Erythropoietin